A bill winding its way through the Texas Senate would strictly regulate lawyer advertising for prescription medication and medical device litigation, and impose a civil penalty for violations under the state’s Deceptive Trade Practices Act.

The Senate State Affairs Committee voted 9-0 to pass a substitute version of Senate Bill 1189 after a public hearing April 4. The bill now heads to the full Senate.